Мальцев Дмитрий Валериевич, кандидат медицинских наук,заместитель директора Института иммунологии и аллергологии Национального медицинского университета имени А. А. Богомольца

Часть 1

Часть 2

Часть 3

Часть 4

Часть 5

Литература:

1. Абатуров А.Б., Шостакович-Корецкая Л.Р. HHV-6 инфекция у детей // Здоровье ребёнка. – 2007. – № 3. – С. 70–80.

2. Барановская Е.И. Герпетическая инфекция в практике акушера-гинеколога // Медицинские новости. – 2001. – № 4. – С. 35–37.

3. Башлыкова М.В., Масюкова С.А., Каримова И.М. Совершенствование современных методов диагностики и лечения герпетической и цитомегаловирусной инфекций // Вестник дерматологии и венерологии. – 2001. – № 5. – С. 12–14.

4. Белова Е.Г., Кускова Т.К. Герпесвирусы 6, 7, 8-го типов // Лечащий врач. – 2006. – № 2. – С. 76–79.

5. Богадельников И. В. Герпесвирусы в организме человека: наказание или благо? // Новости медицины и фармации. – 2007. – № 1. – С. 12–15.

6. Борисова А.М., Лактионова Л.В., Сетдикова Н.Х. Опыт клинического применения полиоксидония при вторичных

7. Глинских Н.П. Герпесвирусы человека // Неизвестная эпидемия: герпес: статьи – Смоленск: Полиграмма, 1997. – С. 57–65.

8. Борисова А.М., Лактионова Л.В., Сетдикова Н.Х. Опыт клинического применения полиоксидония при вторичных иммунодефицитах взрослых // Int. J. Immunorehab. – 1998. – № 10. – С. 100–109.

9. Adour K.K., Ruboyianes J.M., Von Doersten P.G. et al. Bell s palsy treatment with acyclovir and prednisone compared with prednisone alone: а double-blind, randomized, controlled trial. Ann. Otol. Rhino Laryngol. 1996; 105: 371-378.

10. Allen D., Dunn L. Aciclovir or valaciclovir for Bell s palsy (idiopathic facial paralysis). Cochrane Database Syst. Rev. 2004; 3: CD001869.

11. Bach M.C., Bagwell S.P., Knapp N.P. et al. 9-(1,3 dihydroxy-2-propoxymethyl) guanine for cytomegalovirus infections in patients with the acquired immunodeficiency syndrome. Ann. Intern. Med. 1985; 103: 381–384.

12. Bowden R.A., Sayers M., Flournoy N. et al. Cytomegalovirus immunoglobulin and seronegative blood products to prevent primary cytomegalovirus infection after marrow transplantation. N. Engl. J. Med. 1986; 314: 1006–1010.

13. Cheng Y.C., Huang E.S., Lin J.C. et al. Unique spectrum of activity of 9-[(1,3-dihydro-2-propoxy) methyl] guanine against herpes simplex type 1. Proc. Nat. Acad. USA. 1983; 80: 2767–2770.

14. Chou S., Norman D.J. Effect of OKT3 antibody therapy on cytomegalovirus reactivation in renal transplant recipients. Transplantation Proc. 1985; 17: 2755–2756.

15. Cook R.C., Connors J.M, Gascoyne R.D. et al. Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation. Lancet. 1999; 354: 1698-1699.

16. Cundy К.С. Clinical pharmacokinetics of the antiviral nucleotide analogues cidofovir and adefovir. Clin. Pharmacokinet. 1999; 36: 127-43.

17. Darville I.М., Ley B.E., Roome А.Р., Foot A.B. Acyclovir-resistant herpes simplex virus infections in а bone marrow transplant population. Bone Marrow Transplant. 1998; 22: 587-589.

18. Edwards B.S., Merritt J.A., Fuhlbrigge R.C., Borden E.C. Low doses of interferon alpha result in more effective clinical natural killer cell activation. J. Clin. Invest. 1985; 75: 1908–1913.

19. Felsenstein D., D Amico D.J., Hirsch M.S. et al. Treastment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine and high-dose corticosteroids. Ann. Intern. Med. 1985; 105: 214–215.

20. Felsenstein D., D Amico D.J., Hirsch M.S. et al. Treatment of cytomegalovirus retinitis with 9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine. Ann. Intern. Med. 1985; 103: 377–380.

21. Gnann J.W., Crumpacker С.S., Lalezari I.Р. et al. Sorivudine versus acyclovir for treatment of dermatomal herpes zoster in human immunodeficiency virus-infected patients results from а randomized, controlled clinical trial. Antimicrob Agents Chemother. 1998; 42: 1139-45.

22. Gustafson E.A., Chillemi A.C. et al. The Epstein-Barr virus thimidine kinase does not phosphorilate ganciclovir or acyclovir and demonstrates narrov substrate specificity compared to the herpes virus simplex type 1 a thimidine kinase. Antimicrob Agent Chemoterapapy. 1998; 42(11): 2923-2931.

23. Ito Y, Kimura H, Yabuta Y. et al. Exacerbation of herpes simplex encephalitis after successful treatment with acyclovir. Clin. Infect. 2000; 30: 185-87.

24. Kawa-Ha K., Franco E., Dol S., Yumura S. et al. Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet. 1987; 1:154.

25. McGrath N., Anderson N.E., Croxson M.C., Powell K.F. Herpes simplex encephalitis treated with acyclovir: diagnosis and long term outcome. J. Neurol. Neurosurg. Psychiatry. 1997; 63: 321-26.

26. Pate1 R., Bodsworth N.I., Woolley Р. et al. Valaciclovir for the suppression of recurrent genital HSV infection: а placebo controll study of once daily therapy. Genitourin. Меd. 1997; 73: 105-09.

27. Pereyra F., Rubin R.H. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr. Opin. Infect. Dis. 2004; 17: 357–361.

28. Price T.A., Digioia R.A., Simon G.L. Ganciclovir treatment of cytomegalovirus ventriculitis in a patient infected with human immunodeficiency virus. Clin Infect Dis. 1992; 15: 606–608.

29. Pue M.A., Benet L.Z. Pharmacokinetics of famciclovir in man. Antivir. Chem. Chemother. 1993; 4(suppl 11): 47-55.

30. Rea T.L., Thoming С., Tucker R., Saltzman R., Boon R. Penciclovir cream for the treatment of herpes simplex Iabialis А randomized, multicenter, double-blind, placebo-controlled trial. JAMA. 1997; 277: 1374-1379.

31. Reed E.C., Bowden R.A., Dandliker P.S. et al. Treatment of cytomegalovirus pneumonia with ganciclovir and intravenous cytomegalovirus immunoglobulin in patients with bone marrow transplants. Ann. Intern. Med. 1988; 109: 783–78.

32. Safrin S., Crumpacker С., Chatis Р. et al. А controlled trial comparin foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodefficiency syndrome. N. Engl. J. Меd. 1991; 325: 551-55.

33. Schvoerer Е., Frechin V., Warter А. et al. Persistent multiple pulmonary nodules in а nonimmunocompromised woman after varicella-related myelitis treated with acyclovir. J. Curr. Microbiol. 2003; 41: 4904-4905.

34. Straus S.E., Cohen J. I. et al. Epstein-Barr virus infections: biology, pathogenesis, and management. Ann. Inter. Med. 1993: 118: 45-58.

35. Van der Horst, Joncas J. et al. Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J. Infect. Dis. 1991: 164: 788-792. Vere Hodge RA, Cheng УС. The mode of action of penciclovir. Antiviral Chem Chemother 1993; 4(suppl 1): 13-24.

36. Wassilew S.W., Wutzler Р. Oral brivudin in comparison with acyclovir for improved therapy of herpes zoster in immunocompetent patients: results of а randomized, double-blind, multicentered study. Antiviral. Res. 2003; 59: 49-56.

37. Watson C.P., Tyler K.L., Bickers D.R., Millikan L.E., Smith S., Coleman Е. А randomized vehicle-controlled trial of topical capsaicin in the treatment of postherpetic neuralgia. Clin. Ther. 1993; 15: 510-526.

38. Whitley R.J, Alford С.А., Hirsch М.S. et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N .Engl. J. Меd. 1986; 314: 144-149.

39. Jaworska J., Gravel A., Fink K., et al. Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein // J. Virol. – 2007. – Vol. 81(11). – P. 5737-5748.